Assessment of Three-dimensional Vision Alteration in Parkinson Disease

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

June 30, 2014

Conditions
Parkinson Disease
Interventions
OTHER

Psychophysical measurements of 3D perception

3D psychophysical performances using a categorization tasks and their underlying mechanisms measured with visual evoked potentials will be assessed in a randomized and comparative study. The order of psychophysical and visual evoked potentials experiments will be randomized between the L Dopa ON and OFF conditions. The randomization will be done by the clinical investigational center. The comparisons will be made between parkinsonian patient and control subjects, and between parkinsonian patients in L Dopa ON and OFF conditions.

Trial Locations (1)

31059

CHU de Toulouse, Hôpital Purpan, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT01620164 - Assessment of Three-dimensional Vision Alteration in Parkinson Disease | Biotech Hunter | Biotech Hunter